首页> 美国卫生研究院文献>Molecules >Thiophene Derivatives as Anticancer Agents and Their Delivery to Tumor Cells Using Albumin Nanoparticles
【2h】

Thiophene Derivatives as Anticancer Agents and Their Delivery to Tumor Cells Using Albumin Nanoparticles

机译:噻吩衍生物作为抗癌剂并使用白蛋白纳米颗粒将其递送至肿瘤细胞

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A series of thiophene derivatives (TPs) were synthesized and evaluated for cytotoxicity in HepG2 and SMMC-7721 cell lines by MTT assay. TP >5 was identified as a potential anticancer agent based on its ability to inhibit tumor cell growth. Drawbacks of TPs, including poor solubility and high toxicity, were overcome through delivery using self-assembling HSA nanoparticles (NPs). The optimum conditions for TP >5-NPs synthesis obtained by adjusting the temperature and concentration of TP >5. The NPs had an encapsulation efficiency of 99.59% and drug-loading capacity of 3.70%. TP >5 was slowly released from TP >5-NPs in vitro over 120 h. HepG2 and SMMC-7721 cell lines were employed to study cytotoxicity of TP >5-NPs, which exhibited high potency. ROS levels were elevated and mitochondrial membrane potentials reversed when the two cell lines were treated with TP >5-NPs for 12 h. Cellular uptake of fluorescence-labeled TP >5-NPs in vitro was analyzed by flow cytometry and laser confocal scanning microscopy. Fluorescence intensity increased over time, suggesting that TP >5-NPs were efficiently taken up by tumor cells. In conclusion, TP >5-NPs showed great promise as an anticancer therapeutic agent.
机译:合成了一系列噻吩衍生物(TPs),并通过MTT分析评估了其对HepG2和SMMC-7721细胞系的细胞毒性。由于TP > 5 具有抑制肿瘤细胞生长的能力,因此被确定为潜在的抗癌药。通过使用自组装HSA纳米颗粒(NP)进行输送,可以克服TP的缺点,包括溶解性差和毒性高。调节TP > 5 的温度和浓度可得到TP > 5 -NP合成的最佳条件。 NPs的包封率为99.59%,载药量为3.70%。 TP > 5 在超过120小时的时间内从TP > 5 -NPs中缓慢释放。用HepG2和SMMC-7721细胞系研究了TP > 5 -NPs的细胞毒性,该TPs具有较高的效力。当TP > 5 -NPs处理这两个细胞12小时后,ROS水平升高,线粒体膜电位逆转。通过流式细胞仪和激光共聚焦扫描显微镜分析了荧光标记的TP > 5 -NPs在体外的细胞摄取。荧光强度随时间增加,提示TP > 5 -NPs被肿瘤细胞有效吸收。总之,TP > 5 -NPs有望作为一种抗癌治疗剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号